Your browser doesn't support javascript.
loading
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.
Cornish, Nancy E; Anderson, Nancy L; Arambula, Diego G; Arduino, Matthew J; Bryan, Andrew; Burton, Nancy C; Chen, Bin; Dickson, Beverly A; Giri, Judith G; Griffith, Natasha K; Pentella, Michael A; Salerno, Reynolds M; Sandhu, Paramjit; Snyder, James W; Tormey, Christopher A; Wagar, Elizabeth A; Weirich, Elizabeth G; Campbell, Sheldon.
Afiliación
  • Cornish NE; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
  • Anderson NL; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
  • Arambula DG; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
  • Arduino MJ; Centers for Disease Control and Prevention, National Center for Emerging & Zoonotic Infectious Diseases (NCEZID), Atlanta, Georgia, USA.
  • Bryan A; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
  • Burton NC; Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (NIOSH), Cincinnati, Ohio, USA.
  • Chen B; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
  • Dickson BA; Department of Clinical Pathology, Texas Health Presbyterian Hospital Dallas, Dallas, Texas, USA.
  • Giri JG; Centers for Disease Control and Prevention, Center for Global Health (CGH), Atlanta, Georgia, USA.
  • Griffith NK; High Containment Core, Georgia State University, Atlanta, Georgia, USA.
  • Pentella MA; College of Public Health, The University of Iowa, Iowa City, Iowa, USA.
  • Salerno RM; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
  • Sandhu P; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
  • Snyder JW; Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Tormey CA; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Wagar EA; Pathology & Laboratory Medicine Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
  • Weirich EG; Department of Laboratory Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Campbell S; Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Atlanta, Georgia, USA.
Clin Microbiol Rev ; 34(3): e0012618, 2021 06 16.
Article en En | MEDLINE | ID: mdl-34105993
ABSTRACT
Patient care and public health require timely, reliable laboratory testing. However, clinical laboratory professionals rarely know whether patient specimens contain infectious agents, making ensuring biosafety while performing testing procedures challenging. The importance of biosafety in clinical laboratories was highlighted during the 2014 Ebola outbreak, where concerns about biosafety resulted in delayed diagnoses and contributed to patient deaths. This review is a collaboration between subject matter experts from large and small laboratories and the federal government to evaluate the capability of clinical laboratories to manage biosafety risks and safely test patient specimens. We discuss the complexity of clinical laboratories, including anatomic pathology, and describe how applying current biosafety guidance may be difficult as these guidelines, largely based on practices in research laboratories, do not always correspond to the unique clinical laboratory environments and their specialized equipment and processes. We retrospectively describe the biosafety gaps and opportunities for improvement in the areas of risk assessment and management; automated and manual laboratory disciplines; specimen collection, processing, and storage; test utilization; equipment and instrumentation safety; disinfection practices; personal protective equipment; waste management; laboratory personnel training and competency assessment; accreditation processes; and ethical guidance. Also addressed are the unique biosafety challenges successfully handled by a Texas community hospital clinical laboratory that performed testing for patients with Ebola without a formal biocontainment unit. The gaps in knowledge and practices identified in previous and ongoing outbreaks demonstrate the need for collaborative, comprehensive solutions to improve clinical laboratory biosafety and to better combat future emerging infectious disease outbreaks.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Contención de Riesgos Biológicos / Servicios de Laboratorio Clínico Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Microbiol Rev Asunto de la revista: MICROBIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Contención de Riesgos Biológicos / Servicios de Laboratorio Clínico Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Microbiol Rev Asunto de la revista: MICROBIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos